·1 хв читання · 72 слова·👁 6.6K↗ 9
Singapore buys AstraZeneca's Evusheld drug cocktail, which combines 2 long-acting antibodies
The supply of Evusheld, formerly known as AZD7442, is expected to arrive in Singapore by year's end.
Evusheld - made of a combination of 2 long-acting antibodies - reduces risk of severe Covid-19 or death by 88 per cent when patients with mild to moderate infections were treated within 3 days of being symptomatic, according to the drug's Phase 3 trial.
